Companion Diagnostics: World Market Outlook 2011-2021Visiongain
August 22, 2011
108 Pages - SKU: VSG6581757
3.2 Total Companion Diagnostics Market was Worth $1.30bn in 2010
In 2010, the total market for companion diagnostics was estimated to be worth $1.30bn, according to visiongain estimates. This estimate includes the sales of companion diagnostic testing kits and revenues generated through diagnostic testing services provided by the Clinical Laboratory Improvement Amendments (CLIA) certified laboratories in the US and other diagnostic laboratories around the world. As shown in Table 3.1 and Figure 3.1, companion diagnostics currently comprises only a small segment of the total IVD market, which was worth $44.65bn in 2010. In 2010, it contributed only 2.9% of the total IVD market. Companion diagnostics forms a small market at present in 2011.
Advanced Cell Diagnostics
Amoy Diagnostics Company
Bayer Schering Pharma
Biocrates Life Sciences
Biomedical Diagnostics (BMD)
Brain Resource Company
Cancer Research Technology Limited (CRT)
Caris Life Sciences
Centers for Medicare and Medicaid Services (CMS)
Clinical Reference Laboratory
Eli Lilly and Company
European Medicines Agency (EMA)
Hatteras Venture Partners
Inverness Medical Innovations
Johnson & Johnson
Laboratory Corporation of America (LabCorp)
Laboratory for Personalized Molecular Medicine
Life Technologies Corporation
M.D. Anderson Cancer Center
Newcastle University (UK)
Novartis Pharmaceuticals Corporation
Office of In Vitro Diagnostic Device Evaluation and Safety (OIVD)
Oxford Genome Sciences
Quintiles Transnational Corporation
Randox Pharma Services
Roche Molecular Systems
Telegraph Hill Partners
The Netherlands Cancer Institute (NKI)
Third Wave Technologies
Tufts Center for the Study of Drug Development
United HealthCare Services
US Food and Drug Administration (FDA)
US National Institutes of Health (NIH)
Ventana Medical Systems
Weisenthal Cancer Group
More Drug Discovery reports by Visiongain
World Multiple Myeloma Drug Treatment Market 2012-2022 by Visiongain
See what the future holds for products to treat multiple myeloma. Visiongain's updated report gives you revenue predictions to 2022. There you find data, ...
World Pain Relieving Drug Market 2012-2022 by Visiongain
See what the future holds for painkillers. Visiongain's report gives you revenue predictions to 2022. You find data, trends, opportunities and commercial prospects. That ...
Leading Anti-Cancer Drugs and Associated Market 2012-2022 by Visiongain
Cancer treatments - discover which products have greatest potential Where are cancer-treating drugs heading? Visiongain's report shows you potential revenues to 2022, with ...
Antithrombotic/Anticoagulant Drugs: World Market 2012-2022 by VisiongainSee all reports like this >>
Where are antithrombotic and anticoagulant treatments heading? Visiongain's report shows you potential revenues to 2022, with data, forecasts and discussions. This study assesses ...
More Global Drug Discovery reports
Inflammatory Pain Global Clinical Trials Review, H1, 2013 by GlobalData
Inflammatory Pain Global Clinical Trials Review, H1, 2013SummaryGlobalData's clinical trial report, “Inflammatory Pain Global Clinical Trials Review, H1, 2013 provides data on the Inflammatory Pain ...
Cancer Pain Global Clinical Trials Review, H1, 2013 by GlobalData
Cancer Pain Global Clinical Trials Review, H1, 2013SummaryGlobalData's clinical trial report, “Cancer Pain Global Clinical Trials Review, H1, 2013 provides data on the Cancer Pain ...
Ascites Global Clinical Trials Review, H1, 2013 by GlobalData
Ascites Global Clinical Trials Review, H1, 2013SummaryGlobalData's clinical trial report, “Ascites Global Clinical Trials Review, H1, 2013 provides data on the Ascites clinical trial scenario. ...
Radiculopathy Global Clinical Trials Review, H1, 2013 by GlobalDataSee all reports like this >>
Radiculopathy Global Clinical Trials Review, H1, 2013SummaryGlobalData's clinical trial report, “Radiculopathy Global Clinical Trials Review, H1, 2013 provides data on the Radiculopathy clinical trial scenario. ...
We can help you find what you need. Call us or write us:
Need help in your search?
Drug Discovery Reports
- Lab Automation Markets, 3rd. Edition (Systems, Key Companies, Forecasts and Trends)
- Small Animal Imaging (In Vivo) Market - By systems and reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT & Multimodality/Hybrid Imaging Modalities] - Competitive Analysis & Global Forecasts to 2017
- Future Horizons in the Global Therapeutic Drug Monitoring Market: US, Europe, Japan Test Volume and Sales Forecasts by Country and Market Segment
- High Content Screening (HCS)
- ADME-Toxicology Testing